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Abstract 
Background: Keloid is a benign growth of connective tissue. Several risk factors play 
a role in keloid growth. Excision surgery is one of the modalities in the treatment of 
keloids. However, excision surgery alone has a recurrence rate of 45-100%. 
Radiotherapy destroys fibroblast, leads to decreased production of collagen and 
suppressed keloid formation. A study stated that administration of postoperative 
radiation with electrons in keloids on the earlobe at a dose of 15 Gy in three fractions 
gives a low recurrence rate and a low risk of side effects in the surrounding soft tissue.  
Case Presentation: We present a case of recurrent keloid lesion in the left earlobe 
with a history of previous injuries. The lesions was operated on, but always grows back 
postoperatively. The numbers of surgeries that have been carried out three times with 
further treatment in the form of corticosteroid injection. However, keloid still 
recurrence. Finally, it was decided to undergo treatment with surgery followed by 
radiotherapy within no more than 24 hours postoperatively. Radiotherapy as adjuvant 
therapy for postoperative keloid excision has the role of sterilizing the connective 
tissue stem cell active fibroblasts and acute inflammatory cells that grow in the early 
postoperative period. Follow-up after one year gave good results local control without 
recurrence. 
Conclusion: Radiotherapy within no more than 24 hours postoperatively for keloids 
recurrent represents a safe and effective option for control keloid regrowth. 
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INTRODUCTION 
 Keloid is a benign growth of connective tissue with 
a collagen structure due to an imbalance in the wound 
healing process on the skin.1 Keloids are often refractory 
to treatment, recurring frequently. The precise etiology 
and genetic mechanisms of this pathology are still 
unknown. Familial keloids seem to represent an 
incomplete penetrance autosomal dominant disease, 
with varying degrees of clinical severity within a 
pedigree.2,3  
 Several risk factors play a role in keloid growth after 
wound healing, such as genetic factors as the main risk 
factors, melanin, anatomical location, type of injury to 
the skin, age, sex, and blood type, people with blood 
group A have high probability to develop keloids 
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 There is a clear genetic component given the 
correlation with family history, which supported by the 
following phenomena. First, some patients with keloids 
report a positive family history. Second, there is high 
occurrence in identical twins. Third, there is a higher 
predisposition in Blacks, Hispanics, and Asians, less 
frequently in Caucasians. Fourth, increased incidence of 
keloids in patients with some genetic syndromes like 
Turner syndrome, Opitz-Kaveggia syndrome, Rubinstein 
Taybi syndrome, and Ehlers Danlos syndrome.5  
 Most keloids occur three months after injury and 
some cases occur at a distance of one year or more. 
Keloids appear as firm tumor, mildly tender, with a shiny 
surface. Keloids are often pruritic and painful, in addition 
to the significant effects of a patient's quality of life, both 
physically and psychologically, especially in excessive 
scarring.6  
 Excision surgery is one of the modalities in the 




Journal of Biomedicine and Translational Research, 6 (3) 2020, 89-91  
has a recurrence rate of 45-100%. Surgical excision 
followed by radiotherapy is a helpful treatment option 
for large and more difficult-to-treat keloids that cannot 
otherwise be treated by or have failed more conservative 
measures. The balance between proliferation and 
apoptosis is impaired in keloid fibroblasts, and because 
keloid fibroblasts are sensitive to x-ray irradiation, it is 
thought that x-ray radiation may prevent the recurrence 
of keloids by controlling fibroblast proliferation, 
arresting the cell cycle, and inducing premature cellular 
senescence.7 
 Because of the long irradiation waiting list and 
limited radiotherapy center in Indonesia, it has never 
been reported about the use of radiotherapy for keloid in 
Indonesia. In addition, the treatment for keloid requires 
specific radiotherapy equipment, electron beam – 
LINAC (Linear Accelerator). We used comparison case 
from other countries in Asia. Herewith we present an 
evidence-based case report of the utilization of 




 A 37-year old Asian man presented with a left ear 
lobe benign tumor (keloid) for 3 years ago with wound 
history. The patient has a history of keloid formation in 
the chest region with recalled dermal injury or abrasion 
before about 5 years ago, but the keloid did not grow 
rapidly.  There is no patient's family history of keloid. 
The risk factor was not also notable for blood type. In 
physical examination revealed that keloid was firm, 
pliable growth, 9 cm in its greatest diameter, dark brown 
color, with an irregular shape, and itchy. The keloid 
dimension is about 3 x 3 x 9 cm, which caused the patient 
considerable discomfort (Figure 1A). Past medical 
history evinced numerous heterogeneous treatments for 
his ear lobe keloid. He had previously received three 
times surgical extirpation and eight times steroid 
injections (once per month). Despite these interventions, 
his keloids have either recurred or persisted after 1 – 6 
months follow up. Surgical extirpation was undertaken 
but histopathology examination never performed. The 
keloid dimension post-surgical is about 1 x 1 x 3 cm. On 
the day following the fourth surgical excision (eight 
hours after excision), the patient was treated with 
radiotherapy using an electron at 10 MeV. The total dose 
delivered was 15 Gy in 3 days, with a daily fraction of 5 
Gy. Plasticine was used to cover the ear lobe with 1 cm 
thickness and had a role as bolus and tissue compensator. 
Thermoplastic mask was also used as head fixation 
during radiation therapy (Figure 1B). There was no acute 
radiation side effect on his skin during treatment and at 
1-month post-therapy. The patient also reported no 
difficulty attributable to the lesion post radiation therapy. 
At one year after completion of radiation treatment for 
his ear lobe keloids, the patient returned for a follow-up 
examination. No complications and late side effects have 
been noted. The excision combined with radiotherapy 
gave good results without recurrence (Figure 1C).   
 
DISCUSSION 
 Keloid is a benign fibro-proliferative growth 
distinguished by excessive collagen deposition and has a 
high recurrence rate after excision surgery. Excision 
surgery alone has a recurrence rate of 45-100%. Even the 
surgery followed by the administration of corticosteroid 
injection the recurrence rate is not better than surgery 
followed by radiotherapy.8 In this case, the patient 
underwent three-time surgery and corticosteroid 
injection eight times but his keloids have either recurred 
or persisted after 1 - 6 months follow up.    
 Radiotherapy as adjuvant therapy for postoperative 
keloid excision has the role of sterilizing the connective 
tissue stem cell, active fibroblasts, and acute 
inflammatory cells that grow in the early postoperative 
period. The radiotherapy treatment aims to restore a 
balance between collagen formation and breakdown.9 In 
this case, the patient underwent radiotherapy on the day 
following the fourth surgical excision to sterilize the 
connective tissue stem cell, active fibroblasts, and acute 
inflammatory cells that grow in the early postoperative 
period. Shen J, et al Study showed that there was an 
increased relapse rate in person whom radiation occurred 
more than 24 hours after surgery.10     
 
 




Figure 1. (A) Preoperative view. (B) Thermoplastic mask 
with plasticine used during treatment. He underwent 
surgical excision, immediate radiotherapy with a dose of 
15 Gy in three fractions was initiated eight hours on the 
day after the operation. (C) One year postoperatively, no 
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 Meta-analysis was performed including only post 
excisional radiotherapy studies. Keloids site on the chest 
wall higher relapse rate compared with keloids in earlobe 
(HR= 1.91, 95% CI: 1.26–2.89, P < 0.01).11 The lowest 
recurrence rate of 15% was found for brachytherapy with 
23% for electron beam and 23% for X-ray Therapies. 
Recurrence rate comparison between electron beam and 
brachytherapy was statistically insignificant (OR, 1.81; 
P= 0.10), but recurrence rate comparison between X-ray 
and brachytherapy was statistically significant (OR, 1.94 
; P = 0.04).12 In this case, electron beam was performed 
because the contour of the ear lobe surface cannot be 
reached maximally for brachytherapy.   
 A study states that administration of postoperative 
radiation with electrons in keloids in the earlobe at a dose 
of 3 x 5 Gy gives a low recurrence rate and a low risk of 
side effects in the surrounding soft tissue compared to 
high doses radiation per fraction.11 A large study with a 
higher total dose, 18 Gy in two fractions, showed no 
radiation-induced malignancies were observed after a 
median follow up of 40 months, and there was a low 
adverse effect profile of 9.38 percent.11  
 
CONCLUSION 
 In this case, radiotherapy within 24 hours of keloid 
excision has a low recurrence rate compared to surgery 
or surgery followed by the administration of 
corticosteroid injections to controlled regrowth. The 
administration of electron beam radiotherapy with a total 
dose of     15 Gy in post excision ear lobe keloid gave 
good results without recurrence in follow-up after one 
year.  
 The Authors suggest that the patient must do the 
follow-up examination at least four times a year to 
evaluate the late side effect of radiation therapy and the 
possibility of recurrence after complete treatment.    
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